CT1 constellation technologies limited

This was posted on another site: "This week's Feature profiles...

  1. 5 Posts.
    This was posted on another site: "This week's Feature profiles Melbourne, Australia-based Agenix (ASX:AGX; NASDAQ:AGXLY) and its ThromboView monoclonal antibody that detects live blood clots anywhere in the body. As CEO Nicholas Weston tells Leonard Zehr, the company is in partnering talks for ThromboView as it readies the product for Phase 3 clinical trials."

    http://biotuesdays.com/2012/08/07/agenix-readies-thromboview-for-late-stage-clinical-trials/
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $2.949M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
39 34636742 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 7696726 8
View Market Depth
Last trade - 16.21pm 30/07/2025 (20 minute delay) ?
CT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.